Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
237.62B
Market cap237.62B
Price-Earnings ratio
15.29
Price-Earnings ratio15.29
Dividend yield
2.34%
Dividend yield2.34%
Average volume
18.60M
Average volume18.60M
High today
$53.63
High today$53.63
Low today
$52.00
Low today$52.00
Open price
$52.81
Open price$52.81
Volume
19.30M
Volume19.30M
52 Week high
$93.80
52 Week high$93.80
52 Week low
$43.08
52 Week low$43.08

NVO News

TipRanks 13h
GLP-1 Pills Gain Ground: Novo Nordisk Wins FDA Nod as Food Giants Tweak Strategy

The U.S. Food and Drug Administration has approved a weight-loss pill from Novo Nordisk (NVO) that could speed up how appetite-suppressing drugs reach the mass...

Simply Wall St 21h
Novo Nordisk: Reassessing Valuation After Recent Share Price Rebound

Novo Nordisk (NYSE:NVO) has been on a choppy ride lately, with the stock rebounding over the past month after a weaker stretch in the past 3 months and year to...

Novo Nordisk: Reassessing Valuation After Recent Share Price Rebound
TipRanks 1d
Mixed options sentiment in Novo Nordisk with shares up 1.79%

Mixed options sentiment in Novo Nordisk (NVO), with shares up 92c, or 1.79%, near $52.53. Options volume running well above average with 139k contracts traded a...

Analyst ratings

55%

of 33 ratings
Buy
54.5%
Hold
30.3%
Sell
15.2%

More NVO News

Nasdaq 1d
NVO Factor-Based Stock Analysis - Warren Buffett

Below is Validea's guru fundamental report for NOVO NORDISK A/S (ADR) (NVO). Of the 22 guru strategies we follow, NVO rates highest using our Patient Investor m...

NVO Factor-Based Stock Analysis - Warren Buffett
Benzinga 1d
Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval

On Tuesday, the U.S. Food and Drug Administration (FDA) approved Novo Nordisk A/S' (NYSE:NVO) Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess b...

TipRanks 1d
Novo Nordisk Expands Cardiovascular Ambitions With New Phase 3 Ziltivekimab Plaque Study

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Claim 70% Off TipRanks This Holiday Season Study Overview: Novo Nordisk is running a P...

Nasdaq 2d
Company News for Dec 24, 2025

Shares of Novo Nordisk A/S ( NVO ) climbed 7.3% after the U.S. FDA approved its drug GLP-1 pill for the treatment of overweight or obesity. NVO Huntington Inga...

Company News for Dec 24, 2025
TipRanks 2d
Lilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?

U.S.-based Eli Lilly & Co. (LLY) and Danish drug maker Novo Nordisk (NVO) are vying to capture a large portion of India’s rapidly growing obesity drug market. L...

The Motley Fool 2d
Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains

Mega-cap tech and AI stocks carried major indexes in thin holiday trading, while healthcare strength after Novo Nordisk’s Wegovy pill approval added selective s...

Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains
Nasdaq 2d
Why Novo Nordisk Stock Popped Today

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of dia...

Why Novo Nordisk Stock Popped Today
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.